Wockhardt Ltd — Regulatory Filings 2021

Jan 21, 2021

21[st] January, 2021

==> picture [162 x 45] intentionally omitted <==

	BSE LimitedCorporate Relations DepartmentP J TowersDalal StreetMumbai - 400 001Scrip Code: 532300		National Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai - 400 051 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchanges that a meeting of the Board of Directors of the Company will be held on 29[th] January, 2021, interalia , to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31[st] December, 2020.

Further, pursuant to Company's code of conduct for regulating, monitoring, reporting trading by designated persons and as informed vide letter dated 31[st] December, 2020, the Trading window for dealing in the Shares of the Company has been closed from 1[st] January, 2021 and shall remain closed till 31[st] January, 2021. The Trading Window shall re-open with effect from 1[st] February, 2021.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

==> picture [120 x 45] intentionally omitted <==

Gajanand Sahu Company Secretary

==> picture [113 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==